CARL Stock Analysis: Buy, Sell, or Hold?
CARL - Carlsmed, Inc. Common Stock
$12.93
0.34 (2.70%)
▲
5d:
+12.93%
30d:
+14.02%
90d:
+36.39%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Get Alerted When CARL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CARL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CARL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CARL is currently trading at $12.93, which is considered extended relative to its 30-day fair value range of $11.05 to $12.39.
Technical Outlook: Technically, CARL is in a uptrend. Immediate support is located at $10.70, while resistance sits at $13.40.
Market Sentiment: CARL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.60 (+43.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CARL is in a uptrend. Immediate support is located at $10.70, while resistance sits at $13.40.
Market Sentiment: CARL has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.60 (+43.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.05 -
$12.39
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.9% below Wall St target ($18.60)
Trading Range Analysis
30-Day Trading Range
$11.05 -
$12.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.70
Resistance Level
$13.41
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.01
Wall Street Target
$18.60
(+43.9%)
Revenue Growth (YoY)
58.2%
Profit Margin
-57.8%
Share & Embed Analysis
Last updated: August 03, 2026 6:13 PM ET
Data refreshes hourly during market hours. Next update: 7:13 PM
Data refreshes hourly during market hours. Next update: 7:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |